UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q/A

(Amendment No. 1)10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 20212022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission File Number 001-40035

 

LAZARD GROWTH ACQUISITION CORP. I

(Exact Name of Registrant as Specified in its Charter)

 

 

Cayman Islands

 

98-1571783

(State or Other Jurisdiction of Incorporation)

 

(I.R.S. Employer Identification No.)

 

 

 

30 Rockefeller Plaza

New York, New York  

 

10112

(Address of principal executive offices)

 

(zip code)

 

Registrant’s telephone number, including area code: (212) 632-6000

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of Each Exchange on Which Registered

Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant

 

LGACU

 

The Nasdaq Stock Market LLC

Class A ordinary shares, par value $0.0001 per share

 

LGAC

 

The Nasdaq Stock Market LLC

Redeemable warrants, exercisable for one Class A ordinary share at an exercise price of $11.50 per share

 

LGACW

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

  

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes      No  

As of October 15, 2021,November 1, 2022, the registrant had 57,500,000 shares of Class A ordinary shares, $0.0001 par value per share, and 14,375,000 shares of Class B ordinary shares, par value $0.0001 per share issued and outstanding.

 

 

 


EXPLANATORY NOTE

References throughout this Amendment No. 1 to the Quarterly Report on Form 10-Q to “we,” “us,” the “Company” or “our company” are to Lazard Growth Acquisition Corp. I., unless the context otherwise indicates.

This Amendment No. 1 to the Quarterly Report on Form 10-Q/A amends the Quarterly Report on Form 10-Q of Lazard Growth Acquisition Corp. I (the “Company”) as of and for the period ended September 30, 2021, as filed with the Securities and Exchange Commission (“SEC”) on November 4, 2021 (the “Q3 2021 Form 10-Q”).

The financial statements included in the Q3 2021 Form 10-Q included Note 2, Revision of Previously Issued Financial Statements (“Note 2”) that described a revision to the Company’s classification of its Class A ordinary shares subject to redemption issued as part of the units sold in the Company’s initial public offering (“IPO”). As described in Note 2, upon its IPO, the Company classified a portion of the Class A ordinary shares as permanent equity to maintain net tangible assets greater than $5,000,000 on the basis that the Company will consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001. The Company’s management re-evaluated the conclusion and determined that the Class A ordinary shares subject to redemption included certain provisions that require classification of the Class A ordinary shares as temporary equity regardless of the minimum net tangible assets required to complete the Company’s initial business combination.

However, the Company determined at the time that this error was not material to its previously filed financial statements and, therefore, in its financial statements for the quarterly period ended September 30, 2021 in its Q3 2021 Form 10-Q, the Company revised the unaudited condensed financial information in Note 2 to its Q3 2021 Form 10-Q as of March 31, 2021 and June 30, 2021 to classify all Class A ordinary shares as temporary equity. Subsequently, as described below, management re-evaluated the Company’s application of ASC 480-10-S99-3A and determined that the prior classification of a portion of the Class A ordinary shares as permanent equity was a material error. Although the qualitative factors that management assessed tended to support a conclusion that the misstatements were not material, these factors were not strong enough to overcome the significant quantitative errors in the financial statements. The qualitative and quantitative factors support a conclusion that the misstatements are material on a quantitative basis. As such, management re-evaluated the Company’s application of ASC 480-10-S99-3A and determined that the prior classification of a portion of the Class A ordinary shares as permanent equity was a material error.

On December 13, 2021, the Company’s management and the audit committee of the Company’s board of directors (the “Audit Committee”) concluded that the Company’s previously issued (i) audited balance sheet as of February 12, 2021, filed with the SEC on February 19, 2021, (ii) unaudited condensed interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, filed with the SEC on May 12, 2021, (iii) unaudited condensed interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 9, 2021 and (iv) Note 2 to the unaudited condensed financial statements included in the Q3 2021 Form 10-Q (collectively, the “Affected Periods”), should be restated to report all of the Company’s Class A ordinary shares as temporary equity and should no longer be relied upon. As a result, the Company is restating its financial statements for the Affected Periods in this Quarterly Report on Form 10-Q/A to indicate that the classification error is a restatement and not a revision.

The Company determined that none of the above changes had any impact on its previously reported total assets, results of operations or cash flows or on its cash position and cash held in the trust account established in connection with the IPO.

After re-evaluation, the Company’s management has concluded that in light of the error described above, a material weakness existed in the Company’s internal control over financial reporting during the Affected Periods and that the Company’s disclosure controls and procedures were not effective. The Company’s remediation plan with respect to such material weakness is described in more detail in Item 4 of Part I to in this Quarterly Report on Form 10-Q/A.

 


 

Table of Contents

 

 

 

Page

PART I.

FINANCIAL INFORMATION

 

Item 1.

Financial Statements (Unaudited)

 

 

Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021

1

 

Unaudited Condensed Statements of Operations for the Three Months and Nine Months Ended September 30, 2022 and 2021

2

 

Unaudited Condensed StatementStatements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021

3

 

Unaudited Condensed StatementStatements of Changes in Shareholders’ EquityDeficit for the Three Months and Nine Months Ended September 30, 2022 and 2021

4

 

Notes to Unaudited Condensed Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

2116

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

2419

Item 4.

Controls and Procedures

24      19

PART II.

OTHER INFORMATION

 

Item 1.

Legal Proceedings

2720

Item 1A.

Risk Factors

2720

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

2720

Item 3.

Defaults Upon Senior Securities

2820

Item 4.

Mine Safety Disclosures

2820

Item 5.

Other Information

2820

Item 6.

Exhibits

2921

Signatures

3022

 

 

i


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

LAZARD GROWTH ACQUISITION CORP. I

Condensed Unaudited Balance Sheets

 

 

September 30, 2022

 

 

December 31, 2021

 

 

September 30, 2021

 

 

December 31, 2020

 

 

(unaudited)

 

 

(audited)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

55,637

 

 

$

25,000

 

 

$

263,037

 

 

$

660,069

 

Prepaid expenses

 

 

1,320,333

 

 

 

-

 

 

 

345,396

 

 

 

1,056,726

 

Total current assets

 

 

1,375,970

 

 

 

25,000

 

 

 

608,433

 

 

 

1,716,795

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash held in Trust Account

 

 

575,021,845

 

 

 

-

 

Deferred offering costs

 

 

-

 

 

 

629,750

 

Cash equivalents held in Trust Account

 

 

578,594,683

 

 

 

575,033,252

 

TOTAL ASSETS

 

$

576,397,815

 

 

$

654,750

 

 

$

579,203,116

 

 

$

576,750,047

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Promissory note payable

 

$

-

 

 

$

86,750

 

Related party loans

 

 

1,300,000

 

 

 

0

 

 

$

4,000,000

 

 

$

2,000,000

 

Accrued expenses and payable to affiliate

 

 

2,280,844

 

 

 

3,997,673

 

Accrued offering and formation costs

 

 

70,000

 

 

 

550,000

 

 

 

-

 

 

 

70,000

 

Accrued expenses and payable to affiliate

 

 

153,824

 

 

 

-

 

Total current liabilities

 

 

1,523,824

 

 

 

636,750

 

 

 

6,280,844

 

 

 

6,067,673

 

Other liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants exercisable for Class A ordinary shares, at fair value

 

 

16,990,000

 

 

 

-

 

 

 

1,025,000

 

 

 

18,015,000

 

Deferred underwriting commissions

 

 

20,125,000

 

 

 

-

 

 

 

20,125,000

 

 

 

20,125,000

 

Total liabilities

 

 

38,638,824

 

 

 

636,750

 

 

 

27,430,844

 

 

 

44,207,673

 

Commitments and contingencies

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Class A ordinary shares subject to possible redemption; 57,500,000 and 0 shares, respectively, at $10.00 per share

 

 

575,000,000

 

 

 

-

 

Shareholders' Equity

 

 

 

 

 

 

 

 

Preference shares, $0.0001 par value; 5,000,000 shares authorized; NaN issued and outstanding

 

 

-

 

 

 

-

 

Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; NaN issued and outstanding not subject to possible redemption

 

 

-

 

 

 

-

 

Class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 57,500,000 shares issued, outstanding and subject to possible redemption at $10.06 and $10.00 per share, respectively

 

 

578,494,683

 

 

 

575,000,000

 

Shareholders' Deficit

 

 

 

 

 

 

 

 

Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding

 

 

-

 

 

 

-

 

Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 14,375,000 shares issued and outstanding

 

 

1,438

 

 

 

1,438

 

 

 

1,438

 

 

 

1,438

 

Additional paid in capital

 

 

-

 

 

 

23,562

 

 

 

-

 

 

 

-

 

Retained earnings (accumulated deficit)

 

 

(37,242,447

)

 

 

(7,000

)

Total shareholders' equity

 

 

(37,241,009

)

 

 

18,000

 

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

 

$

576,397,815

 

 

$

654,750

 

Accumulated Deficit

 

 

(26,723,849

)

 

 

(42,459,064

)

Total shareholders' deficit

 

 

(26,722,411

)

 

 

(42,457,626

)

TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT

 

$

579,203,116

 

 

$

576,750,047

 

 

The accompanying notes are an integral part of these condensed financial statements.

1


LAZARD GROWTH ACQUISITION CORP. I

Condensed Unaudited Statements of Operations

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

September 30,

 

 

2021

 

 

2021

 

 

2022

 

 

2021

 

2022

 

 

2021

 

EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

$

486,806

 

 

$

1,313,865

 

 

$

418,462

 

 

$

486,806

 

$

1,321,533

 

 

$

1,313,865

 

Total expenses

 

 

486,806

 

 

 

1,313,865

 

 

 

418,462

 

 

 

486,806

 

 

1,321,533

 

 

 

1,313,865

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expensed offering costs

 

 

-

 

 

 

(714,494

)

Change in fair value of warrant liability

 

 

6,405,000

 

 

 

5,560,000

 

 

 

4,280,000

 

 

 

6,405,000

 

16,990,000

 

 

 

5,560,000

 

Interest on trust account

 

 

9,989

 

 

 

21,845

 

 

 

2,785,173

 

 

 

9,989

 

3,561,431

 

 

 

21,845

 

Total other income (expenses)

 

 

6,414,989

 

 

 

4,867,351

 

Expensed offering costs

 

 

-

 

 

 

-

 

 

-

 

 

 

(714,494

)

Total other income

 

 

7,065,173

 

 

 

6,414,989

 

 

20,551,431

 

 

 

4,867,351

 

NET INCOME

 

$

5,928,183

 

 

$

3,553,486

 

 

$

6,646,711

 

 

$

5,928,183

 

$

19,229,898

 

 

$

3,553,486

 

Weighted average number of shares outstanding, redeemable Class A ordinary shares

 

 

57,500,000

 

 

 

48,653,846

 

 

 

57,500,000

 

 

 

57,500,000

 

 

57,500,000

 

 

 

48,653,846

 

Basic and diluted net income per share, redeemable Class A ordinary shares

 

$

0.08

 

 

$

0.06

 

 

$

0.09

 

 

$

0.08

 

$

0.27

 

 

$

0.06

 

Weighted average number of shares outstanding, non-redeemable ordinary shares

 

 

14,375,000

 

 

 

14,375,000

 

Basic and diluted net income per share, non-redeemable ordinary shares

  

$

0.08

 

 

$

0.06

 

Weighted average number of shares outstanding, non-redeemable Class B ordinary shares

 

 

14,375,000

 

 

 

14,375,000

 

 

14,375,000

 

 

 

14,375,000

 

Basic and diluted net income per share, non-redeemable Class B ordinary shares

 

$

0.09

 

 

$

0.08

 

$

0.27

 

 

$

0.06

 

 

The accompanying notes are an integral part of these condensed financial statements.

2


LAZARD GROWTH ACQUISITION CORP. I

Condensed Unaudited StatementStatements of Cash Flows

 

 

Nine Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2021

 

 

2022

 

 

2021

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

 

$

3,553,486

 

 

$

19,229,898

 

 

$

3,553,486

 

Adjustments to reconcile net income to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrant liability

 

 

(5,560,000

)

 

 

(16,990,000

)

 

 

(5,560,000

)

Expensed offering costs

 

 

714,494

 

 

 

-

 

 

 

714,494

 

Interest on trust account

 

 

(21,845

)

 

 

(3,561,431

)

 

 

(21,845

)

(Increase) decrease in operating assets and increase (decrease) in operating liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Prepaid expenses

 

 

(1,320,333

)

 

 

711,330

 

 

 

(1,320,333

)

Accrued expenses and payable to affiliates

 

 

153,824

 

Accrued expenses and payable to affiliate

 

 

(1,716,829

)

 

 

153,824

 

Accrued offering and formation costs

 

 

(70,000

)

 

 

-

 

Net Cash used in operating activities

 

 

(2,480,374

)

 

 

(2,397,032

)

 

 

(2,480,374

)

Investing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Cash placed in trust

 

 

(575,000,000

)

 

 

-

 

 

 

(575,000,000

)

Cash used in investing activities

 

 

(575,000,000

)

 

 

-

 

 

 

(575,000,000

)

Financing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from related party loans

 

 

2,000,000

 

 

 

1,300,000

 

Proceeds from sale of Initial Public Offering Units

 

 

575,000,000

 

 

 

-

 

 

 

575,000,000

 

Proceeds from sale of Private Placement Warrants

 

 

13,500,000

 

 

 

-

 

 

 

13,500,000

 

Payment of underwriting discount

 

 

(11,500,000

)

 

 

-

 

 

 

(11,500,000

)

Payment of offering costs

 

 

(702,239

)

 

 

-

 

 

 

(702,239

)

Proceeds from promissory note payable

 

 

100,833

 

 

 

-

 

 

 

100,833

 

Payment of promissory note payable

 

 

(187,583

)

 

 

-

 

 

 

(187,583

)

Proceeds from related party loans

 

 

1,300,000

 

Net cash provided by financing activities

 

 

577,511,011

 

 

 

2,000,000

 

 

 

577,511,011

 

Net Change in Cash

 

 

30,637

 

 

 

(397,032

)

 

 

30,637

 

Cash - Beginning of period

 

 

25,000

 

 

 

660,069

 

 

 

25,000

 

Cash - End of period

 

$

55,637

 

 

$

263,037

 

 

$

55,637

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Deferred offering costs included in accrued offering and formation costs

 

$

70,000

 

 

$

-

 

 

$

70,000

 

Deferred underwriting commission

 

$

20,125,000

 

 

$

-

 

 

$

20,125,000

 

Remeasurement of value of Class A ordinary shares subject to possible redemption

 

$

3,494,683

 

 

$

-

 

 

The accompanying notes are an integral part of these condensed financial statements.

 

 


LAZARD GROWTH ACQUISITION CORP. I

Condensed Unaudited StatementStatements of Changes in Shareholders’ EquityDeficit

For the nine monthsNine Months ended September 30, 2022 and September 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Retained

Earnings

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Total

 

 

Class A Ordinary Shares

 

 

Class B Ordinary Shares

 

 

Paid in

 

 

(Accumulated

 

 

Shareholders'

 

 

Class A Ordinary Shares

 

 

Class B Ordinary Shares

 

 

Paid in

 

 

Accumulated

 

 

Shareholders'

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit)

 

 

Equity

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

Balance, December 31, 2020

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

23,562

 

 

$

(7,000

)

 

$

18,000

 

Balance, January 1, 2022

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(42,459,064

)

 

$

(42,457,626

)

Net Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,596,916

 

 

 

6,596,916

 

Balance, March 31, 2022

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(35,862,148

)

 

$

(35,860,710

)

Net Income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,986,271

 

 

 

5,986,271

 

Remeasurement of value of Class A ordinary shares subject to possible redemption

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(709,510

)

 

 

(709,510

)

Balance, June 30, 2022

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(30,585,387

)

 

$

(30,583,949

)

Net Income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,646,711

 

 

 

6,646,711

 

Remeasurement of value of Class A ordinary shares subject to possible redemption

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,785,173

)

 

 

(2,785,173

)

Balance, September 30, 2022

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(26,723,849

)

 

$

(26,722,411

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Total

 

 

Class A Ordinary Shares

 

 

Class B Ordinary Shares

 

 

Paid in

 

 

Accumulated

 

 

Shareholders'

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

Balance, January 1, 2021

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

23,562

 

 

$

(7,000

)

 

$

18,000

 

Class A ordinary shares issued, net of offering costs

 

 

57,500,000

 

 

 

5,750

 

 

 

-

 

 

 

-

 

 

 

530,624,927

 

 

 

-

 

 

 

530,630,677

 

 

 

57,500,000

 

 

 

5,750

 

 

 

-

 

 

 

-

 

 

 

530,624,927

 

 

 

-

 

 

 

530,630,677

 

Proceeds of sale of Private Placement Warrants in excess of fair value

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,600,000

 

 

 

-

 

 

 

3,600,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,600,000

 

 

 

-

 

 

 

3,600,000

 

Net Income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,103,432

 

 

 

1,103,432

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,103,432

 

 

 

1,103,432

 

Class A ordinary shares subject to possible redemption

 

 

(57,500,000

)

 

 

(5,750

)

 

 

-

 

 

 

-

 

 

 

(534,248,489

)

 

$

(40,745,761

)

 

 

(575,000,000

)

 

 

(57,500,000

)

 

 

(5,750

)

 

 

-

 

 

 

-

 

 

 

(534,248,489

)

 

 

(40,745,761

)

 

 

(575,000,000

)

Balance, March 31, 2021 - as restated

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(39,649,329

)

 

$

(39,647,891

)

Balance, March 31 2021

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(39,649,329

)

 

$

(39,647,891

)

Offering costs on Class A ordinary shares issued

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(43,172

)

 

 

(43,172

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(43,172

)

 

 

(43,172

)

Net Loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,478,129

)

 

 

(3,478,129

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,478,129

)

 

 

(3,478,129

)

Balance, June 30, 2021 - as restated

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(43,170,630

)

 

$

(43,169,192

)

Net Income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,928,183

 

 

 

5,928,183

 

Balance, June 30, 2021

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(43,170,630

)

 

$

(43,169,192

)

Net Loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,928,183

 

 

 

5,928,183

 

Balance, September 30, 2021

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

 

(37,242,447

)

 

$

(37,241,009

)

 

 

-

 

 

$

-

 

 

 

14,375,000

 

 

$

1,438

 

 

$

-

 

 

$

(37,242,447

)

 

$

(37,241,009

)

 

 

The accompanying notes are an integral part of these condensed financial statements.

 


 

LAZARD GROWTH ACQUISITION CORP. I

Notes to Unaudited Condensed Financial Statements

Note 1 - Organization and Plan of Business Operations

Lazard Growth Acquisition Corp. I(the “Company”) is a blank check company, incorporated as a Cayman Islands exempted company on December 10, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company, as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of September 30, 2021,2022, the Company had not commenced any operations. The Company’s business activitiesAll activity for the three and nine months ended September 30, 2022 and 2021, primarily relatedrelates to the company’s formation, completing its initial public offering (“Initial Public Offering”) and identifying and evaluating prospective acquisition targets for an initial Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

The registration statement for the Initial Public Offering became effective on February 9, 2021. On February 12, 2021, the Company consummated the Initial Public Offering of 57,500,000 units (the “Units”), including 7,500,000 Units sold upon exercise in full of the underwriter’s over-allotment option, at $10.00 per Unit, which is discussed inNote4, and the sale of 9,000,000 warrants, including 1,000,000 warrants upon the exercise of the underwriter’s over-allotment option in full (the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant in a private placement to LGACo 1 LLC (the “Sponsor”), that closed simultaneously with the closing of the Initial Public Offering.

Substantially allThe Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement WarrantsWarrants. Although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80%80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50%50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Initial Public Offering, the Companyagreed that $10.00 per Unit sold in the Initial Public Offering, including a portion of the proceeds of the sale of the Private Placement Warrants, were placed in a trust account (“Trust Account”) to be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earliest of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.

The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, based on a variety of factors. The Public Shareholders will be entitled to redeem their public shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially anticipated to be $10.00 per public share), including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to certain limitations. The per-share amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 9)6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares will be have been classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” (“ASC 480”)


The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the SEC,Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor and each of our officers and directors have agreed to vote their Founder Shares (as defined in Note 6)3) and any public shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their public shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the public shares without the Company’s prior written consent.

The Sponsor and each of our officers and directors have agreed to waive their redemption rights with respect to any Founder Shares and public shares held by them in connection with (i) the completion of a Business Combination and (ii) a shareholder vote to approve an amendment to the Amended and Restated Memorandum and Articles of Association that (A) modify the substance or timing of the Company’s obligation to allow redemption of Class A ordinary shares in connection with the Company’s initial Business Combination or to redeem 100% of the public shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights. Additionally, the Sponsor and each of our officers and directors have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to consummate a Business Combination within the Combination Period. However, if the Sponsor or each of our officers and directors acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period.

The Company has until 24 months from the closing of the Initial Public Offering to consummate a Business Combination (or such extended time beyond 24 months as a result of a shareholder vote to amend its Amended and Restated Memorandum and Articles of Association) (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with


respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.


The Sponsor and each of our executive officers and directors have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares they hold if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of our executive officers and directors acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive its rights to deferred underwriting commissions (see Note 69)) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Ppublic shares.ublic Shares. In the event of such distributionredemption,, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per public share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party or prospective target business that executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 global pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

LiquidityGoing Concern Consideration

On March 26, 2021, the Sponsor committed $1,300,000 to be provided to the Company to fund working capital requirements prior to an initial Business Combination. On August 5, 2021, the Sponsor amended its working capital loan to provide additional borrowingborrowings up to a total amount of $2,000,000. TheOn March 30, 2022, the Sponsor further amended the working capital loan to provide additional borrowing up to a total borrowing of $5,000,000. After borrowing $4,000,000, the Company had cash of $263,037 as of September 30, 2022 and the Company does not have sufficient liquidity to meet its anticipated obligations during the period beginning with the date of issuance of these financial statements through the end of the Combination Period, (the date at which the Company will cease operations if a Business Combination has not been completed). In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management determined that while the Sponsor or an affiliate of the Sponsor may, but is not obligated to, loan the Company additional funds as may be needed by the Company. As of September 30, 2021, the Company, after drawing down $1,300,000 on the workingthe Company cannot assure you that their plans to raise capital loan, had cash of $55,637 available for working capital purposes. The working capital loan is payable upon the completion of a business combination. As of September 30, 2021, the Company has $153,824 of accrued expenses and offering costs. Management expects these sources of funds will provide sufficient liquidityor to fund the Company’s working capital needs through the earlier of the consummation of the initial Business Combination or November 4, 2022, one year after the date these financial statements were issued.  

Note 2 - Restatement of Previously Issued Financial Statements

In accordance with the terms of the Amended and Restated Memorandum and Articles of Association, the Company will proceed with a Business Combination only if the Company hasnettangible assets ofat least $5,000,001. Previously, the Company reported as temporary equity the amount of Class A ordinary shares subject to redemption that included the total number of shares able to be redeemed that would comply with the provision in the Amended and Restated Memorandum and Articles of Association and underwriting agreement and that would not precludecomplete a Business Combination and shareholder redemptions from occurring. However, in preparation of the financial statements of the Companywill be successful. These factors, among others, raise substantial doubt about our ability to continue as of and for the quarterly period ended September 30, 2021, the Company re-evaluated the Company’s application of ASC 480-10-S99-3A to its accounting classification of Class A ordinary shares. Upon re-evaluation, management determined that the Class A ordinary shares issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management concluded that the redemption value should include all Class A ordinary shares subject to possible redemption, regardless of the minimum net tangible assets required by the Company to complete its initial Business Combination. The Company determined at the time that this error was not material to its previously filed financial statements and, therefore, in its financial statements for the quarterly period ended September 30, 2021 in its Q3 2021 Form 10-Q, the Company revised the unaudited condensed financial information in Note 2 to its Q3 2021 Form 10-Q as of March 31, 2021 and June 30, 2021 to classify all Class A ordinary shares as temporary equity. Upon further consideration of the change, the Company determined that the change in classification of the Class A ordinary shares is material quantitatively and it should restate its previously issued financial statements and such financial statements should no longer be relied upon. On December 13, 2021, the Company’s management and the Audit Committee concluded that the Company’s previously issued (i) audited balance sheet as of February 12, 2021, filed with the SEC on February 19, 2021, (ii) unaudited condensed interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, filed with the SEC on May 12, 2021, (iii) unaudited condensed interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 9, 2021 and (iv) Note 2 to the unaudited condensed financial statements included in the Q3 2021 Form 10-Q, should be restated to report all of the Company’sClass A ordinary shares as temporary equity and should no longer be relied upon. As a result, the Company is restating its financial statements for the Affected Periods in this Quarterly Report on Form 10-Q/A to indicate that the classification error is a restatement and not a revision. The Class A ordinary shares subject to possible redemption included in temporary equity at September 30, 2021, represent 100% of the outstanding Class A ordinary shares.going concern.


The impact of the restatement on the Company’s financial statements is reflected in the following tables.


BALANCE SHEETS

 

 

 

February 12, 2021

 

 

 

As previously

reported

 

 

Restatement Adjustment

 

 

As Restated

 

Temporary Equity:

 

 

 

 

 

 

 

 

 

 

 

 

Class A ordinary shares subject to possible redemption

 

$

551,085,017

 

 

$

23,914,983

 

 

$

575,000,000

 

Permanent Equity:

 

 

 

 

 

 

 

 

 

 

 

 

Class A ordinary shares

 

$

239

 

 

$

(239

)

 

$

-

 

Class B ordinary shares

 

 

1,438

 

 

 

-

 

 

 

1,438

 

Additional paid in capital

 

 

5,005,460

 

 

 

(5,005,460

)

 

 

-

 

Retained earnings (accumulated deficit)

 

 

(7,135

)

 

 

(18,909,284

)

 

 

(18,916,419

)

Total Shareholders' Equity

 

$

5,000,002

 

 

$

(23,914,983

)

 

$

(18,914,981

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2021

 

 

 

As previously

reported

 

 

Restatement Adjustment

 

 

As Restated

 

Temporary Equity:

 

 

 

 

 

 

 

 

 

 

 

 

Class A ordinary shares subject to possible redemption

 

$

530,352,107

 

 

$

44,647,893

 

 

$

575,000,000

 

Permanent Equity:

 

 

 

 

 

 

 

 

 

 

 

 

Class A ordinary shares

 

$

446

 

 

$

(446

)

 

$

-

 

Class B ordinary shares

 

 

1,438

 

 

 

-

 

 

 

1,438

 

Additional paid in capital

 

 

3,901,686

 

 

 

(3,901,686

)

 

 

-

 

Retained earnings (accumulated deficit)

 

 

1,096,432

 

 

 

(40,745,761

)

 

 

(39,649,329

)

Total Shareholders' Equity

 

$

5,000,002

 

 

$

(44,647,893

)

 

$

(39,647,891

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2021

 

 

 

As previously

reported

 

 

Restatement Adjustment

 

 

As Restated

 

Temporary Equity:

 

 

 

 

 

 

 

 

 

 

 

 

Class A ordinary shares subject to possible redemption

 

$

526,830,806

 

 

$

48,169,194

 

 

$

575,000,000

 

Permanent Equity:

 

 

 

 

 

 

 

 

 

 

 

 

Class A ordinary shares

 

$

482

 

 

$

(482

)

 

$

-

 

Class B ordinary shares

 

 

1,438

 

 

 

-

 

 

 

1,438

 

Additional paid in capital

 

 

7,379,779

 

 

 

(7,379,779

)

 

 

-

 

Retained earnings (accumulated deficit)

 

 

(2,381,697

)

 

 

(40,788,933

)

 

 

(43,170,630

)

Total Shareholders' Equity

 

$

5,000,002

 

 

$

(48,169,194

)

 

$

(43,169,192

)


STATEMENTS OF OPERATIONS

 

 

 

Three Months March 31, 2021

 

 

 

As previously

reported

 

 

Restatement Adjustment

 

 

As Restated

 

Weighted average number of shares outstanding, redeemable Class A ordinary shares

 

 

28,297,868

 

 

 

2,368,799

 

 

 

30,666,667

 

Basic and diluted net income per share, redeemable Class A ordinary shares

 

$

0.00

 

 

$

0.02

 

 

$

0.02

 

Weighted average number of shares outstanding, non-redeemable ordinary shares

 

 

16,743,799

 

 

 

(2,368,799

)

 

 

14,375,000

 

Basic and diluted net income per share, non-redeemable ordinary shares

 

$

0.07

 

 

$

(0.05

)

 

$

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2021

 

 

 

As previously

reported

 

 

Restatement Adjustment

 

 

As Restated

 

Weighted average number of shares outstanding, redeemable Class A ordinary shares

 

 

53,035,211

 

 

 

4,464,789

 

 

 

57,500,000

 

Basic and diluted net loss per share, redeemable Class A ordinary shares

 

$

0.00

 

 

$

(0.05

)

 

$

(0.05

)

Weighted average number of shares outstanding, non-redeemable ordinary shares

 

 

18,839,789

 

 

 

(4,464,789

)

 

 

14,375,000

 

Basic and diluted net loss per share, non-redeemable ordinary shares

 

$

(0.19

)

 

$

0.14

 

 

$

(0.05

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30, 2021

 

 

 

As previously

reported

 

 

Restatement Adjustment

 

 

As Restated

 

Weighted average number of shares outstanding, redeemable Class A ordinary shares

 

 

40,374,875

 

 

 

3,782,584

 

 

 

44,157,459

 

Basic and diluted net loss per share, redeemable Class A ordinary shares

 

$

0.00

 

 

$

(0.04

)

 

$

(0.04

)

Weighted average number of shares outstanding, non-redeemable ordinary shares

 

 

17,797,584

 

 

 

(3,422,584

)

 

 

14,375,000

 

Basic and diluted net loss per share, non-redeemable ordinary shares

 

$

(0.13

)

 

$

0.09

 

 

$

(0.04

)

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

 

 

 

Three Months Ended March 31, 2021

 

 

 

As previously

reported

 

 

Restatement Adjustment

 

 

As Restated

 

Change in Class A ordinary shares subject to possible redemption

 

$

(530,352,107

)

 

$

(44,647,893

)

 

$

(575,000,000

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2021

 

 

 

As previously

reported

 

 

Restatement Adjustment

 

 

As Restated

 

Change in Class A ordinary shares subject to possible redemption

 

$

3,521,301

 

 

$

(3,521,301

)

 

$

-

 


 

Note 32 - Significant Accounting Policies

Basis of Presentation

The Company’s unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the SEC for interim financial information and the instructions to Form 10-Q. Certain disclosures included in the annual financial statements have been condensed or omitted from these financial statements as they are not required for interim financial statements under U.S. GAAP and the rules of the SEC. These unaudited condensed financial


statements reflect all adjustments that are, in the opinion of management, necessary for a fair statement of the results for the interim periodperiods presented. These adjustments are of a normal, recurring nature. Interim period operating results may not be indicative of the operating results for a full year.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements included in the Company’s final prospectus for the Initial Public Offering filed with the SEC on February 11, 2021, as well as the Company’s annual audited financial statements included in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2021.2022. The interim results for the three months and nine months ended September 30, 20212022 are not necessarily indicative of the results to be expected for the year ending December 31, 20212022 or for any future interim periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regardingexecutivecompensationinitsperiodicreportsandproxystatements,andexemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companiesfrombeingrequiredto comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means thatwhen a standard is issued or revised and ithasdifferent application dates forpublic orprivate companies,the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor anemerging growth company which has opted out of using the extended transition period difficult or impossible becauseofthepotentialdifferencesinaccountingstandardsused.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Estimates, by their nature, are based on judgment and available information. Therefore, actual results could differ from those estimates and could have a material impact on the financial statements.


Cash and Cash Equivalents Held in Trust Account

Cash andincludes cash equivalents include cash on hand and on deposit at a banking institutions as well as all highly liquid short-term investments with original maturities of ninety (90) days or less. As of September 30, 2021, theinstitution. The Company held depositscash of $55,637$263,037 and $660,069 in a demand deposit account at September 30, 2022 and December 31, 2021, respectively. The company held $575,021,845cash equivalents of $578,594,683 and $575,033,252 in the Trust Account as of September 30, 2022 and December 31, 2021, respectively. The cash equivalents held in the Trust Account are characterized as a Level I investmentsinvestment within the fair value hierarchy under ASC 820. The cash equivalents held in the Trust Account isare held in money market funds which invest only in direct U.S. Treasury obligations and are considered restricted.

Deferred Offering Costs

Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering. These costs, together with the upfront underwriting discounts, the deferred underwriting commissions and the financial advisory fee in connection with the Initial Public Offering, were allocated between the Public Shares and the Public Warrants and charged to shareholders’ equity and operating expenses, respectively, upon the completion of the Initial Public Offering.

Warrants Exercisable for Class A Ordinary Shares

The Company accounts for the warrants issued in connection with the Initial Public Offering in accordance with ASC 480-10, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity,” which provides that the Company classifies the warrant instrument as a liability at its fair value and adjusts the instrument to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, in accordance with ASC Topic 815, and any change in fair value is recognized in the Company’s statement of operations.

Income Taxes

The Company accounts for income taxes under ASC 740, "Income Taxes." ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 20212022 and December 31, 20202021 there were 0no unrecognized tax benefits and 0no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.


The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was 0zero for the periods presented.

Redeemable Shares of Class A Ordinary Shares Subject to Possible Redemption

As discussed in Note 1, all of the 57,500,000 shares ofThe Company accounts for its Class A ordinary shares sold as parts of the Unitssubject to possible redemption in the Initial Public Offering contain a redemption feature. In accordance with the guidance in ASC 480,480. Common stock subject to mandatory redemption provisions not solelyis classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the Company requireholder or subject to redemption upon the securityoccurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be classified outside of permanent equity.the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

Each month, the Company re-measures the redemption value of the Class A shares subject to possible redemption. During the three and nine months ended September 30, 2022, the cumulative net interest income earned on the Trust Account exceeded the $100,000 available to be used by the Company for liquidation costs should the Company not complete a Business Combination. The remeasurement as of September 30, 2022 and 2021 allresulted in an increase of $3,494,683 and $0, respectively, to the 57,500,000 shares of Class A ordinary shares included in the Units were classified outside of permanent equity.redemption value and a charge to accumulated deficit.


Net Income (Loss) Per Ordinary Share

Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares issued and outstanding during the period.period, excluding ordinary shares subject to forfeiture. As of September 30, 2022 and 2021, the Company had outstanding warrants to purchase up to 20,500,000 shares of Class A ordinary shares. The weighted average of these shares have been excluded from the calculation of diluted net income (loss) per share of redeemable Class A ordinary shares because the exercise of the warrants is contingent upon theoccurrence of future events. As ofAt September 30, 2022 and 2021, the Company did 0tnot have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of ordinary shares and then share in the income earnings (losses) of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

The Company’s statement of operations includes a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss) per share, basic and diluted, for redeemable Class A ordinary shares is calculated by dividing the investment income earned on the Trust Account by the weighted average number of redeemable Class A ordinary shares outstanding. Net income (loss) per share, basic and diluted, for non-redeemable ordinary shares is calculated by dividing the net income (loss), adjusted for income attributable to redeemable Class A ordinary shares, by the weighted average number of non-redeemable ordinary shares outstanding for the period. Non-redeemable ordinary shares include the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value measurements and disclosures,” approximates the carrying amounts represented in the accompanying balance sheets primarily due to their short-term nature. 

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

In August 2020, the Financial Accounting Standards Board issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and


freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Note 4 - Initial Public Offering

On February 12, 2021, pursuant to the Initial Public Offering, the Company sold 57,500,000 Units, including 7,500,000 Units sold upon exercise in full of the underwriter’s over-allotment option, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-fifth of one redeemable warrant (“Public Warrant”). Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share atanexercisepriceof$11.50perwholeshare, subject to adjustment(seeNote10).


Transaction costs amounted to $32,476,988, consisting of $11,500,000 of underwriting fees (that includes a $3,000,000 financial advisory fee paid to Lazard Frères & Co. LLC for which the Company was reimbursed by the underwriter), $20,125,000 of deferred underwriting fees and $851,988 of other offering costs.

Note 5 - Private Placement

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 9,000,000 Private Placement Warrants at a priceof $1.50 per Private Placement Warrant, for an aggregate purchase price of $13,500,000. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 10). A portion of the proceeds from the Private Placement Warrants were added totheproceeds from theInitial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the public shares (subject to the requirements of applicable law) and the Private Placement Warrants will expireworthless.

The proceeds from the sale of the Private Placement Warrants of $13,500,000 exceeded their estimated fair value of $9,900,000 at the closing of the private placement by $3,600,000, which was recorded in additional paid in capital.

Note 63 - Related Party Transactions

Founder Shares

On December 17, 2020, the Sponsor paid $25,000 to purchase an aggregate of 14,375,000 Class B ordinary shares (the “Founder Shares”)sothatthenumberof Founder Shares will equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering.

On February 5, 2021, the Sponsor transferred 25,000 of its Founder SharesClass B ordinary shares (the “Founder Shares”) to each of the Company’s 5five independent directors (125,000 Founder Shares in the aggregate). Further, on February 5, 2021, the Sponsor converted into a series limited liability company and LGA HoldCo LLC, an affiliate of Lazard Ltd, provided each of the Company’s officers and certain other employees of Lazard Ltd and its subsidiaries the opportunity to purchase certain membership interests in a series of the Sponsor (the “Series Membership Interests”) pursuant to which such persons have economic interests in certain of the Founder Shares but do not have voting rights or dispositive power with respect thereto. In particular, as of February 12, 2021, the Company’s officers and such other employees of Lazard Ltd and its subsidiaries possess Series Membership Interests representing economic interests in approximately 30% in the aggregate of the Company’s issued and outstanding Founder Shares, including approximately 2% in the aggregate which has been provided by the Company’s officers; however, the Sponsor maintains the voting rights attributable to, and the dispositive power in respect of, all such Founder Shares. Each of the Company’s officers and such other employees of Lazard Ltd and its subsidiaries will also be eligible to directly or indirectly purchase or receive additional economic or other interests in the Company’s securities from Lazard Ltd and its subsidiaries, including additional Series Membership Interests, on a discretionary basis in the future.

Effective May 11, 2021, a member of the Company’s board of directors (the “Board”) resigned his position as a member of the Board and subsequently transferred back to the Sponsor the 25,000 Founder Shares he previously received from the Sponsor in connection with his service on the Board.

The Sponsor’s transfer of 100,000 Founders Shares to the Company’s directors is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 100,000 shares transferred to the Company’s directors was $342,000 or $3.42 per share. The Founders Shares were effectively transferred subject to a performance condition (i.e., the consummation of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date a Business Combination is considered probable in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) As of September 30, 2022, the Company has not yet entered into any definitive agreements in connection with any Business Combination. Any such agreements may be subject to certain conditions to closing, such as, for example, approval by the Company’s shareholders. As a result, the Company determined that the consummation of a Business Combination is not yet considered probable, and, therefore, no stock-based compensation expense has been recognized. 

The Sponsor and each of the Company’sour executive officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of: (i) one year after the completion of a Business Combination and (ii) subsequent to a Business Combination, (A) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (B) the date on which the Company


completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.

IPO Promissory Note

On December 17, 2020, the Sponsor agreed to loan the Company an aggregate amount of up to $300,000 to be used to pay a portion of the expenses related to the Initial Public Offering, pursuant to an unsecured revolving promissory note (the “IPO Promissory Note”).  The IPO Promissory Note was non-interest bearing and payable on the earlier of (i) March 31, 2021 or (ii) the completion of the Initial Public Offering. On February 12, 2021, upon consummation of the Initial Public Offering, the borrowings outstanding under the IPO Promissory Note of $187,583 were repaid in full and the IPO Promissory Note was cancelled.

Related Party Loans

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor has committed $1,300,000 to be provided to the Company (“Working Capital Loan”) to fund our expenses relating to investigating and selecting a target business and other working capital requirements prior to anour initial Business Combination. business combination. On August 5, 2021, the Sponsor amended its commitment to provide up to $2,000,000 of borrowing in the aggregate. In addition,On March 30, 2022, the Sponsor or an affiliatefurther amended the Working Capital Loan to provide additional borrowing up to a total borrowing of the Sponsor may, but are not obligated to, loan the Company additional funds as may be required (“Working Capital Loans”). $5,000,000. If the Company completes a Business Combination, the Company may repay the Working Capital LoansLoan out of the proceeds of the Trust Account released to the Company.In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans,Loan, but 0no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except Loan.fortheforegoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.

At the lender’s discretion, up to $2,000,000 of such Working Capital Loans Loan may be convertible into warrants of the post-Business Combination entity at a price of $1.50 $1.50 per warrantwarrant.. The warrants would be identical to the Private Placement Warrants. As of September 30, 2021 and December 31, 2020, the Company had $1,300,000 and $0 outstanding borrowings, respectively, under the Working CapitalLoans.

Advisory Services

Lazard Frères & Co. LLC, an affiliate of the Company, is acting as the Company’s independent financial advisor as defined under Financial Industry Regulatory Authority (“FINRA”) Rule 5110(j)(9), to provide independent financial consulting services, consisting of a review of deal structure and terms and related structuring advice in connection with the Initial Public Offering and the consummation of the Business Combination.  Upon the completion of the Initial Public Offering, Lazard Frères & Co. LLC received a financial advisory fee of $3,000,000. Pursuant to the terms of the underwriting agreement,Working Capital Loan, as amended on March 30, 2022, such conversion right may only be exercised at the underwriter agreedtime of a Business Combination. The warrants would be identical to reimburse the Private Placement Warrants. As of September 30, 2022 and December 31, 2021, the Company for a portionhad $4,000,000 and $2,000,000, respectively, outstanding borrowings under the Working CapitalLoan.


In addition, the Sponsor or an affiliate of the offering costs in an amount equal Sponsor may, but are not obligated to, loan the fee paidCompany additional funds (“Supplemental Loans”) as may be required. The terms of such Supplemental Loans, if any, have not been determined and no written agreements exist with respect to Lazard Frères & Co. LLC. On February 12, 2021, the underwriter reimbursed the Company $3,000,000.such loans.

Administrative Support Agreement

The Company agreed, commencing on the date that the Company’s securities are first listed on the Nasdaq Capital Market, which was February 10, 2021, and through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $20,000 per month for office space, secretarial and administrative support. For the three months ended September 30, 2022 and 2021, the Company incurred administrative expenses of $60,000 and for the nine months ended September 30, 2022 and 2021, the Company incurred administrative expenses of $180,000 and $160,000, respectively.

Note 74 - Fair Value Measurements

Fair Value Hierarchy of Assets and Liabilities—The Company categorizes its warrants exercisable for Class A ordinary shares, which are recorded at fair value into a three-level fair value hierarchy as follows:

Level 1. Assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market    that the Company has the ability to access.


Level 2. Assets and liabilities whose values are based on (i) quoted prices for similar assets or liabilities in an active market, or quoted prices for identical or similar assets or liabilities in non-active markets, or (ii) inputs other than quoted prices that are directly observable or derived principally from, or corroborated by, market data.

Level 3. Assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect our own assumptions about the assumptions a market participant would use in pricing the asset or liability

 


The Company’s Public Warrants exercisable for Class A ordinary shares began trading on Nasdaq in April 2021 and have beenat such time they were reclassified from Level 3 to Level 1. Their fair value at September 30, 2022 and December 31, 2021 is based on an observable market quote. The fair value of the Public Warrants prior to the commencement of trading and the fair value of the Private Warrants as of December 31, 2021 and September 30, 2021, is based on a valuation model that utilizes both observable and unobservable inputs. Observable inputs include the market pricesprice of the Company’s Class A Ordinary shares and the exercise price of the warrants issued by other SPACs and unobservable. Unobservable inputs include the time to maturity, a risk free interest rate and annualized volatility of the Company’s Class A Ordinary shares. At September 30, 2022, such valuation model adjustmentscould not be used to determine the fair value of the Private Warrants because the implied volatility for valuation uncertainty pertainingthe Public Warrants was unsolvable, due to the probabilityfair value of the Company consummatingPublic Warrants declining from $0.87 at December 31, 2021 to $0.05 at September 30, 2022. As a Business Combination.result, at September 30, 2022, the fair market value of Public Warrants was used to determine the fair value of the Private Warrants.

The following table presents,tables present, as of September 30, 2022 and December 31, 2021, the classification of assets and liabilities measured at fair value on a recurring basis within the fair value hierarchy.

 

 

September 30, 2021

 

 

September 30, 2022

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

NAV

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash Held in Trust Account

 

$

575,021,845

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

575,021,845

 

Cash equivalents held in Trust Account

 

$

578,594,683

 

 

$

-

 

 

$

-

 

 

$

578,594,683

 

Total

 

$

575,021,845

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

575,021,845

 

 

$

578,594,683

 

 

$

-

 

 

$

-

 

 

$

578,594,683

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants exercisable for Class A ordinary shares

 

$

9,430,000

 

 

$

-

 

 

$

7,560,000

 

 

$

-

 

 

$

16,990,000

 

 

$

575,000

 

 

$

-

 

 

$

450,000

 

 

$

1,025,000

 

Total

 

$

9,430,000

 

 

$

-

 

 

$

7,560,000

 

 

$

-

 

 

$

16,990,000

 

 

$

575,000

 

 

$

-

 

 

$

450,000

 

 

$

1,025,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2021

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents held in Trust Account

 

$

575,033,252

 

 

$

-

 

 

$

-

 

 

$

575,033,252

 

Total

 

$

575,033,252

 

 

$

-

 

 

$

-

 

 

$

575,033,252

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants exercisable for Class A ordinary shares

 

$

10,005,000

 

 

$

-

 

 

$

8,010,000

 

 

$

18,015,000

 

Total

 

$

10,005,000

 

 

$

-

 

 

$

8,010,000

 

 

$

18,015,000

 


 

The following tables provide a summary of the changes in fair value of the Company’s Level 3 liabilities for the three months and nine months ended September 30, 2021.2022 and 2021 respectively.

 

 

Three Months ended September 30, 2021

 

 

Three Months ended September 30, 2022

 

 

Beginning

Balance

 

 

Initial Fair Value

 

 

Changes in Fair Value of Warrant Liabilities

 

 

Transfers

 

 

Ending Balance

 

 

Beginning

Balance

 

 

Changes in Fair Value of Warrant Liabilities

 

 

Transfers

 

 

Ending Balance

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Private Warrants exercisable for Class A ordinary shares

 

$

10,170,000

 

 

$

-

 

 

$

(2,610,000

)

 

$

-

 

 

$

7,560,000

 

 

$

2,430,000

 

 

$

(1,980,000

)

 

$

-

 

 

$

450,000

 

Total Level 3 Liabilities

 

$

10,170,000

 

 

$

-

 

 

$

(2,610,000

)

 

$

-

 

 

$

7,560,000

 

 

$

2,430,000

 

 

$

(1,980,000

)

 

$

-

 

 

$

450,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months ended September 30, 2022

 

 

Beginning

Balance

 

 

Changes in Fair Value of Warrant Liabilities

 

 

Transfers

 

 

Ending Balance

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Private Warrants exercisable for Class A ordinary shares

 

$

8,010,000

 

 

$

(7,560,000

)

 

$

-

 

 

$

450,000

 

Total Level 3 Liabilities

 

$

8,010,000

 

 

$

(7,560,000

)

 

$

-

 

 

$

450,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months ended September 30, 2021

 

 

Beginning

Balance

 

 

Changes in Fair Value of Warrant Liabilities

 

 

Transfers

 

 

Ending Balance

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Private Warrants exercisable for Class A ordinary shares

 

$

10,170,000

 

 

$

(2,610,000

)

 

$

-

 

 

$

7,560,000

 

Total Level 3 Liabilities

 

$

10,170,000

 

 

$

(2,610,000

)

 

$

-

 

 

$

7,560,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months ended September 30, 2021

 

 

Initial Fair Value February 12, 2021

 

 

Changes in Fair Value of Warrant Liabilities

 

 

Transfers

 

 

Ending Balance

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Public Warrants exercisable for Class A ordinary shares

 

$

12,650,000

 

 

$

(1,150,000

)

 

$

(11,500,000

)

 

$

-

 

Private Warrants exercisable for Class A ordinary shares

 

 

9,900,000

 

 

 

(2,340,000

)

 

 

-

 

 

 

7,560,000

 

Total Level 3 Liabilities

 

$

22,550,000

 

 

$

(3,490,000

)

 

$

(11,500,000

)

 

$

7,560,000

 

 

 

 

Nine Months ended September 30, 2021

 

 

 

Beginning

Balance

 

 

Initial Fair Value

 

 

Changes in Fair Value of Warrant Liabilities

 

 

Transfers

 

 

Ending Balance

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Public Warrants exercisable for Class A ordinary shares

 

$

-

 

 

$

12,650,000

 

 

$

(1,150,000

)

 

$

(11,500,000

)

 

$

-

 

Private Warrants exercisable for Class A ordinary shares

 

 

-

 

 

 

9,900,000

 

 

 

(2,340,000

)

 

 

-

 

 

 

7,560,000

 

Total Level 3 Liabilities

 

$

-

 

 

$

22,550,000

 

 

$

(3,490,000

)

 

$

(11,500,000

)

 

$

7,560,000

 


 

Note 85 - Derivatives

The Company’s derivative instruments pertain to the Public Warrants and Private Placement Warrants, and are stated at their fair values and are included in “warrants exercisable for Class A ordinary shares” on the condensed unaudited balance sheets.

 


The following table providestables provide a summary of the changes in fair value of the Company’s derivative instruments for the three months and nine months ended September 30, 2022 and 2021.

 

 

Nine Months ended September 30, 2022

 

 

Warrants Exercisable for Class A Ordinary Shares

 

 

Public

 

 

Private

 

 

Total

 

Balance January 1, 2022

 

$

10,005,000

 

 

$

8,010,000

 

 

$

18,015,000

 

Change in fair value for the three months ended March 31, 2022

 

 

(3,910,000

)

 

 

(3,150,000

)

 

 

(7,060,000

)

Balance as of March 31, 2022

 

$

6,095,000

 

 

$

4,860,000

 

 

$

10,955,000

 

Change in fair value for the three months ended June 30, 2022

 

 

(3,220,000

)

 

 

(2,430,000

)

 

 

(5,650,000

)

Balance as of June 30, 2022

 

$

2,875,000

 

 

$

2,430,000

 

 

$

5,305,000

 

Change in fair value for the three months ended September 30, 2022

 

 

(2,300,000

)

 

 

(1,980,000

)

 

 

(4,280,000

)

Balance as of September 30, 2022

 

$

575,000

 

 

$

450,000

 

 

$

1,025,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months ended September 30, 2021

 

 

Warrants Exercisable for Class A Ordinary Shares

 

 

Warrants Exercisable for Class A Ordinary Shares

 

 

Public

 

 

Private

 

 

Total

 

 

Public

 

 

Private

 

 

Total

 

Balance January 1, 2021

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

Initial Fair Value

 

 

12,650,000

 

 

 

9,900,000

 

 

 

22,550,000

 

 

 

12,650,000

 

 

 

9,900,000

 

 

 

22,550,000

 

Change in fair value as of March 31, 2021

 

 

(1,150,000

)

 

 

(900,000

)

 

 

(2,050,000

)

Change in fair value for the three months ended March 31, 2021

 

 

(1,150,000

)

 

 

(900,000

)

 

 

(2,050,000

)

Balance as of March 31, 2021

 

 

11,500,000

 

 

 

9,000,000

 

 

 

20,500,000

 

 

$

11,500,000

 

 

$

9,000,000

 

 

$

20,500,000

 

Change in fair value as of June 30, 2021

 

 

1,725,000

 

 

 

1,170,000

 

 

 

2,895,000

 

Change in fair value for the three months ended June 30, 2021

 

 

1,725,000

 

 

 

1,170,000

 

 

 

2,895,000

 

Balance as of June 30, 2021

 

 

13,225,000

 

 

 

10,170,000

 

 

 

23,395,000

 

 

$

13,225,000

 

 

$

10,170,000

 

 

$

23,395,000

 

Change in fair value as of September 30, 2021

 

 

(3,795,000

)

 

 

(2,610,000

)

 

 

(6,405,000

)

Change in fair value for the three months ended September 30, 2021

 

 

(3,795,000

)

 

 

(2,610,000

)

 

 

(6,405,000

)

Balance as of September 30, 2021

 

$

9,430,000

 

 

$

7,560,000

 

 

$

16,990,000

 

 

$

9,430,000

 

 

$

7,560,000

 

 

$

16,990,000

 

 

Note 96 - Commitments and Contingencies

Registration and Shareholders Rights

The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital LoansLoan (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and the warrants that may be issued upon conversion of the Working Capital Loans) will beLoan) are entitled to registration rights pursuant to a registration and shareholder rights agreement executed in connection withsigned on February 9, 2021. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Initial Public Offering.Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination. However, the registration and shareholder rights agreement provides that the Company willis not permitrequired to cause any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the Founder Shares, as described under the heading “Founders Shares” in Note 6,3, and (ii) in the case of the Private Placement Warrantsprivate placement warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of a Business Combination. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’sCompany's securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.


Underwriting Agreement

The Company granted the underwriter a 45-day option to purchase up to 7,500,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The underwriter exercised this over-allotment option in full on February 10, 2021.

The underwriter received a cash underwriting discount of $0.20 per Unit, or $11,500,000 in the aggregate, upon the closing of the Initial Public Offering. In addition, the underwriter will beis entitled to deferred commissions of $0.35 per Unit, or $20,125,000 in the aggregate. aggregate. The deferred commissions will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination within the Combination Period, subjecttothetermsofthe terms of the underwriting agreement.agreement.

Note 107 - Shareholders’ Equity

Preference Shares

The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Board. At September 30, 2021 and December 31, 2020, there were 0 preference shares issued or outstanding.


Class A Ordinary Shares

The Company is authorized to issue 500,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At September 30, 2021 and December 31, 2020, there were 0 Class A ordinary shares issued or outstanding (net of Class A ordinary shares subject to redemption).

Class B Ordinary Shares

The Company is authorized to issue 50,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At September 30, 2021 and December 31, 2020, there were 14,375,000 Class B ordinary shares issued and outstanding. On February 10, 2021, in connection with the underwriter’s exercise of the over-allotment option in full, 1,875,000 Class B ordinary shares are no longer subject to forfeiture.

Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except (i) as required bylaw and (ii) with respect to the election of directors.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued ordeemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding Class A ordinary shares or equity-linked securities exercisableexercisable for or convertible into Class A ordinary shares issued, deemed issued,, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

Warrants Exercisable for Class A Ordinary Shares

Public Warrants may only be exercised for a whole number of shares. NaN fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (i) 30 days after the completion of a Business Combination and (ii) one year from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption orliquidation.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt underthesecuritieslawsofthestateofresidenceoftheregisteredholderofthewarrants.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class Aordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing ofaBusiness Combination, andto maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Class A ordinary shares are at the time of any exercise ofawarrant notlistedonanational securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company


may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption isnotavailable.Ifaregistrationstatement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company has failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is notavailable.

Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described with respect to the Private Placement Warrants):

in whole and not in part;

at a price of $0.01 perwarrant;

upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Companysendsthenoticeofredemptiontothewarrantholders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securitieslaws.

Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00.

Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;

at $0.10 per warrant

upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A ordinary shares;

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted) on the trading day prior to the date the Company sends the notice of redemption to the warrantholders.

If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis.”The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except in certain circumstances, the Public Warrants will notbeadjusted forissuances ofordinary shares ataprice belowits exercise price. Additionally, in no event will the Company be required to net cash settle thePublic Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held intheTrust Account, holders ofPublic Warrants will notreceive anyof such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expireworthless.


The Private Placement Warrants areidentical to the Public Warrants underlying the Unitssold inthe Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limitedexceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except in certain circumstances, so long as they are held by the Sponsor orits permitted transferees. Ifthe Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company andexercisablebysuch holdersonthesamebasisasthePublicWarrants.

Note 118 - Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in these financial statements.

* * * * *


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion should be read in conjunction with the Company’s condensed financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q (thefor the quarterly period ended September 30, 2022 (this “Form 10-Q”), as well as Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) included in the Company’s Annual Report on Form 10-K for the period from December 10, 2020 (inception) throughyear ended December 31, 20202021 filed with the SEC on March 31, 2022 (the Company’s “Form 10-K”). Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements other than statements of historical fact included in this Form 10-Q including statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the SEC on February 11, 2021.Form 10-K. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Lazard Ltd, an affiliate of our Sponsor, intends to use resources across its international financial advisory and asset management businesses to source and evaluate attractive, high growth private companies. Although we are not limited to a particular industry or geographic region in our identification and acquisition of a target company, we believe the growth-oriented subsectors of the healthcare, technology, energy transition, financial and consumer sectors present particularly attractive investment opportunities.

At September 30, 2021,2022 we had cash of $55,637$263,037 and cash equivalents held in a Trust Account of $575,021,845,$578,594,683, current liabilities of $1,523,824,$6,280,844, deferred underwriting commission payable of $20,125,000 and warrants for the purchase of Class A ordinary shares of $16,630,000.$1,025,000. Further, we expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an initial Business Combination will be successful.

Results of Operations

For the three months ended September 30, 2022, we had net income of $6,646,711, which consisted of a change in the fair value of warrants exercisable for Class A ordinary shares of $4,280,000 and interest income of $2,785,173 earned on funds held in the Trust Account. This income was partially offset by general and administrative fees of $418,462. Interest earned on the Trust Account is restricted to the redemption or liquidation of Class A ordinary shares and cannot be used for the Company’s business activities.

For the three months ended September 30, 2021, we had a net income of $5,928,183, which consisted of a change in the fair value of warrants exercisable for Class A ordinary shares of $6,405,000 and interest income$9,989 of $9,989interest earned on funds held in the Trust Account. This income was partiallyThese revenues were offset by general and administrative feesexpenses of $486,806. Interest earned on the Trust Account is restricted to the redemption or liquidation of Class A ordinary


shares and cannot be used for the Company’s business activities. Our business activities for the three months ended September 30, 2022 and 2021 primarily related to identifying and evaluating prospective acquisition targets for an initial Business Combination.

For the nine months ended September 30, 2022, we had a net income of $19,229,898, which consisted of a change in the fair value of warrants exercisable for Class A ordinary shares of $16,990,000 and interest income of $3,561,431 earned on funds held in the Trust Account. These revenues were offset by general and administrative expenses of $1,321,533. Interest earned on the Trust Account is restricted to the redemption or liquidation of Class A ordinary shares and cannot be used for the Company’s business activities. Our business activities for the threenine months ended September 30, 20212022 primarily related to identifying and evaluating prospective acquisition targets for an initial Business Combination.


For the nine months ended September 30, 2021, we had a net income of $3,553,486, which consisted of a change in the fair value of warrants exercisable for Class A ordinary shares of $5,560,000 and interest income$21,845 of $21,845interest earned on funds held in the Trust Account. This income was partiallyThese revenues were offset by general and administrative fees of $1,313,865 and offering costs that were expensed of $714,494 related to the closing of our Initial Public Offering. Interest earned on the Trust Account is restricted to the redemption or liquidation of Class A ordinary shares and cannot be used for the Company’s business activities. Our business activities for the nine months ended September 30, 2021 includedprimarily related to completing our Initial Public Offering, and since the offering, our activity has been limited to identifying and evaluating prospective acquisition targets for an initial Business Combination.

We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We expect to continue to generate non-operating income in the form of interest income on cash equivalents held in the Trust Account. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.costs.

Liquidity and Capital Resources

On February 12, 2021, we consummated our Initial Public Offering of 57,500,000 of our Units, including 7,500,000 Units sold upon exercise in full of the underwriter’s over-allotment option. Each Unit consists of one Class A ordinary share of the Company, $0.0001 par value per share, and one-fifth of one Public Warrant, with each whole Public Warrant entitling the holder thereof to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $575,000,000. Goldman Sachs & Co. LLC acted as Book-Running Manager. The securities sold in the Initial Public Offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-252408), which was declared effective by the SEC on February 9, 2021.

Simultaneously with the consummation of the Initial Public Offering and the issuance and sale of the Units, the Company consummated the sale to the Sponsor of 9,000,000 Private Placement Warrants, with each Private Placement Warrant exercisable to purchase one Class A ordinary share at $11.50 per share subject to adjustment, at a price of $1.50 per Private Placement Warrant, generating total proceeds of $13,500,000. The Private Placement Warrants are identical to the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees, (i) they will not be redeemable by us, (ii) they (including the Class A ordinary shares issuable upon exercise of these Private Placement Warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by our Sponsor until 30 days after the completion of our initial Business Combination, (iii) they may be exercised by the holders on a cashless basis and (iv) they will be entitled to registration rights.

A total of $575,000,000, comprised of $563,500,000 of the proceeds from the Initial Public Offering and $11,500,000 of the proceeds from the sale of the Private Placement Warrants, was placed in the Trust Account. Transaction costs amounted to $32,476,988, consisting of $11,500,000 of underwriting fees (a net underwriting fee of $8,500,000 after giving effect to the underwriter’s reimbursement of the Company for $3,000,000 of financial advisory fees payable by the Company to Lazard Frères & Co. LLC), $20,125,000 of deferred underwriting fees (as may be reduced as a result of the underwriter’s reimbursement to the Company for certain financial advisory fees payable by the Company to Lazard Frères & Co. LLC) and $851,988 of other offering costs.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable and deferred underwriting commissions), to complete our initial Business Combination. We may withdraw interest income (if any) to pay taxes, if any. Any remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, the Sponsor has, as of August 5, 2021,March 30, 2022 amended the working capital loan to increase the borrowing limit from $1,300,000$2,000,000 to $2,000,000$5,000,000 to be provided to us to fund our expenses relating to investigating and selecting a target business and other working capital requirements prior to our initial Business Combination. In addition, the Sponsor or an affiliate of the Sponsor may, but is not obligated to, loan us additional funds as may be required. If we complete our initial Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that our initial Business Combination does not close, we may use a


portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment.

Up to $2,000,000 of such loansthe working capital loan may be convertibleconverted into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants.

In addition, the Sponsor or an affiliate of the Sponsor may, but is not obligated to, loan us additional funds as may be required. Except for the foregoing, the terms of such additional loans have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial Business Combination, we do not expect to seek loans from parties other than our Sponsor or its affiliates as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account.

We may need to obtain additional financing to complete our initial Business Combination, either because the transaction requires more cash than is available from the proceeds held in the Trust Account, or because we become obligated to redeem a significant number of our public shares upon completion of the Business Combination, in


which case we may issue additional securities or incur debt in connection with such Business Combination. If we have not consummated our initial Business Combination within the required time period because we do not have sufficient funds available to us, we would be forced to cease operations and liquidate the Trust Account.

Going Concern Assessment

As of September 30, 2022, the Company had cash of $263,037 and $2,280,844 of accrued expenses. The Company forecasts additional expenses through February 12, 2023 (the final date to complete a business combination) totaling $292,700 and $100,000 of interest income.  The Company’s total forecasted cash outflows through February 12, 2023, net of $100,000 interest income for liquidation costs, totals $2,473,544, which leaves the company with a forecasted cash shortfall of $2,210,507. As of September 30, 2022, the Company does not have sufficient liquidity to meet its anticipated obligations during the period beginning with the date of issuance of these financial statements through the end of the Combination Period. The Company cannot assure you that its plans to raise capital or to complete a Business Combination will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.

Off-balance Sheet Financing Arrangements

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements.

We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or entered into any non-financial agreements involving assets.

Contractual Obligations

At September 30, 2021,2022, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. On February 10, 2021, we entered into an administrative support agreement pursuant to which we have agreed to pay an affiliate of the Sponsor a total of $20,000 per month for office space, administrative and support services. Upon the earlier of the completion of the Initial Business Combination and the Company’s liquidation, we will cease paying these monthly fees.

The underwriter of the Initial Public Offering received a cash underwriting discount of $0.20 per Unit, or $11,500,000 in the aggregate, upon the closing of the Initial Public Offering. In addition, the underwriter will beis entitled to deferred commissions of $0.35 per Unit, or $20,125,000 in the aggregate. The deferred underwriting discountcommissions will be paid to the underwriter solely in the event that the Company completes a Business Combination within the time required, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following as our critical accounting policies:

Net Income Per Ordinary Share

We comply with accounting and disclosure requirements of ASC Topic 260, Earnings Per Share. Net income per share of ordinary shares is computed by dividing net income by the weighted average number of common shares outstanding during the period. We apply the two-class method in calculating earnings per share. Adjustments associated with the redeemable shares of Class A ordinary shares under ASC Topic 480-S993 are excluded from


earnings per share as the redemption value approximates fair value and we elect to reflect changes in redemption value immediately as they occur through Additional-Paid-In-Capital.

As of September 30, 2022 and September 30, 2021, we had outstanding warrants to purchase of up to 20,500,000 shares of Class A ordinary shares. The weighted average of these shares was excluded from the calculation of diluted net income per share of ordinary shares since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2022 and September 30, 2021, we did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into shares of ordinary shares and then share in our earnings. As a result, diluted income per common share is the same as basic income per common share for the period.

Deferred Offering Costs

We comply with the requirements of the ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A —“Expenses of Offering.” We incurred offering costs in connection with our Initial Public Offering of $851,988. These costs, together with the upfront underwriter discount and deferred discount of $31,625,000, were charged to the shares of our Class A ordinary shares and warrants upon the closing of our Public Offering.

Warrants

Under ASC Topic 815, we have classified issued warrants as liabilities remeasured at fair value, with changes in fair value each period reported to earnings. 

Class A Ordinary Shares Subject to Possible Redemption

In accordance with the terms of the Amended and Restated Memorandum and Articles of Association, theThe Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001. Previously, the Company reported as temporary equity the amount ofaccounts for its Class A ordinary shares subject to possible redemption that included the total number of shares able to be redeemed that would complyin accordance with the provisionguidance in the Amended and Restated Memorandum and Articles of Association and underwriting agreement and that would not preclude a Business Combination and shareholder redemptions from occurring. Management determined that the ordinary shares issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management concluded that the redemption value should include allASC 480. Accordingly, Class A ordinary shares subject to possible redemption resulting inare presented as temporary equity, outside of the ordinary shares subject to possible redemption being equal to their redemption value.shareholders’ deficit section of the Company’s balance sheets. The Class A ordinary shares subject to possible redemption included in temporary equity at September 30, 2022 and December 31, 2021, represent 100% of the outstanding Class A ordinary shares.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

As of September 30, 2021, we were not subject to any market or interest rate risk.Not required for smaller reporting companies.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. 

Under the supervision and with the participation of ourOur management, including our principal executive officerChief Executive Officer and principal financial and accounting officer, we conducted an evaluation ofChief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)pursuant to Rule 13a-15 under the Exchange Act)Act as of the end of the fiscal quarter ended September 30, 2021.period covered by this quarterly report. Based upon thison that evaluation, our principal executive officerChief Executive Officer and principal financial and accounting officerChief Financial Officer have concluded that, as of the end of the period covered by this quarterly report, our disclosure controls and procedures were not(as defined in Rule 13a-15(e) under the Exchange Act) are effective as of September 30, 2021, due solely to a material weaknessensure that information we are required to disclose in our internal control over financial reporting. A


materialweaknessreports that we file or submit under the Exchange Act is a deficiency, or a combination of deficiencies,recorded, processed, summarized and reported within the time periods specified in internal control over financial reporting,Securities and Exchange Commission rules and forms, and that such that thereinformation is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Specifically,accumulated and communicated to our management, has concluded thatincluding our control around the interpretationChief Executive Officer and accounting for certain complex financial instruments was not effectively designed or maintained. This material weakness resulted in the restatement of the Company’s balance sheetChief Financial Officer, as of February 12, 2021 and its interim financial statements for the quarters ended March 31, 2021 and June 30, 2021. This material weakness is furtherdescribed below in “Changes in Internal Control Over Financial Reporting.”appropriate, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

Except as set forth below,During the quarter ended September 30, 2022, there washave been no changechanges in our internal control over financial reporting (as defined in RulesRule 13a-15(f) and 15d-15(f) under the Exchange Act). that occurred during the fiscal quarter of 2021 covered by this Quarterly Report that hashave materially affected, or isare reasonably likely to materially affect, our internal control over financial reporting.

 

Our internal control over financial reporting did not result in the proper classification of all redeemable Class A ordinary shares as temporary equity within our previously issued financial statements. Historically, a portion of our Class A ordinary shares was classified as permanent equity to maintain net tangible assets greater than $5,000,000 on the basis that we will consummate our initial Business Combination only if we have net tangible assets of at least $5,000,001. In preparation of the Q3 2021 Form 10-Q, the Company re-evaluated the Company’s application of ASC 480-10-S99-3A to its accounting classification of its Class A ordinary shares. Pursuant to such re-evaluation, the Company’s management determined that our Class A ordinary shares include certain provisions that require classification of the Class A ordinary shares as temporary equity regardless of the minimum net tangible assets required to complete our initial Business Combination. The Company determined at the time that this error was not material to previously filed financial statements and, therefore, in its financial statements in the Q3 2021 Form 10-Q, the Company revised its financial statements as of March 31, 2021 and June 30, 2021 to classify all Class A ordinary shares as temporary equity. Subsequently, as described below, management re-evaluated the Company’s application of ASC 480-10-S99-3A and determined that the prior classification of a portion of the Class A ordinary shares as permanent equity was a material error.

Therefore, in consultation with the Audit Committee, on December 13, 2021, we concluded that our previously issued (i) audited balance sheet as of February 12, 2021, filed with the SEC on February 19, 2021, (ii) unaudited condensed interim financial statements included in our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 filed with the SEC on May 12, 2021, (iii) unaudited condensed interim financial statements included in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 9, 2021 and (iv) Note 2 to the unaudited condensed financial statements included in the Q3 2021 Form 10-Q, should be restated to report all of the Company’s Class A ordinary shares as temporary equity and should no longer be relied upon. As a result, the Company is restating its financial statements for the Affected Periods in this Quarterly Report on Form 10-Q/A to indicate that the classification error is a restatement and not a revision. As such, we have restated our financial statements for the Affected Periods in this Quarterly Report, as described in Note 2 of the notes to the financial statements included herein. 

Notwithstanding the identified material weakness, management believes that the financial statements and related financial information included in this Quarterly Report fairly present, in all material respects, our balance sheets, statements of operations and cash flows as of and for the periods presented.

Remediation Plan


Following the identification of the material weakness described above with respectin 2021, as previously disclosed in the Company’s Annual Report on Form 10-K for the period ended December 31, 2021, our Chief Executive Officer and Chief Financial Officer implemented a plan of remediation to strengthen our internal control over financial reporting, which was comprised of the accounting treatmentperformance of our Class A ordinary shares, our principal executive officer and principal financial and accounting officer performed additional accounting and financial analyses related to the classification of our Class A ordinary shares as temporary equity versus permanent equity, includingas well as consulting with subject matter experts. We are inThese procedures and expanded review processes were extended to our complex securities, including but not limited to redeemable Class A shares, convertible debt and stock purchase warrants. As a result of these additional procedures, which began during the process of evaluating whether additional remediation measures should be implemented with respect to such material weakness.

As we continue to evaluatequarterly period ending December 31, 2021, our management, including our Chief Executive Officer and improve our financial reporting process, we may take additional actions to modify certainChief Financial Officer, has concluded that, as of the remediation measures described above. We cannot assure you thatend of the measures we have taken


to date, or any measures we may takeperiod covered by this quarterly report, our disclosure controls and procedures (as defined in Rule 13a-15(e) under the future, will be sufficient to remediate the material weakness we have identified or avoid potential future material weaknesses.Exchange Act) are effective.



PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

As of the date of this Quarterly Report on Form 10-Q, thereThere were no material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the period ended December 31, 2020, except for the below risk factor. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.2021.

We have identified a material weakness in our internal control over financial reporting. If we are unable to develop and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results.

As described elsewhere in this Quarterly Report on Form 10-Q/A, we have identified a material weakness in our internal control over financial reporting related to the Company’s accounting and reporting of complex financial instruments, including application of ASC 480-10-S99-3A to its accounting classification of public shares. As a result of the material weakness, our management has concluded that our disclosure controls and procedures were not effective as of September 30, 2021. See “Note 2-Restatement of Previously Issued Financial Statements” to the accompanying financial statements, as well as Part I. Item 4. Controls and Procedures included in this Quarterly Report on Form 10-Q/A. We have taken a number of measures to remediate the material weakness described herein. However, if we are unable to remediate our material weakness in a timely manner or we identify additional material weaknesses, we may be unable to provide required financial information in a timely and reliable manner and we may incorrectly report financial information. Likewise, if our financial statements are not filed on a timely basis, we could be subject to sanctions or investigations by the stock exchange on which our securities are listed, the SEC or other regulatory authorities. The existence of a material weakness in internal control over financial reporting could adversely affect our reputation or investor perceptions of us, which could have a negative effect on the trading price of our securities. We can give no assurance that the measures we have taken and plan to take in the future will remediate the material weakness identified or that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure to implement and maintain adequate internal control over financial reporting or circumvention of these controls. Even if we are successful in strengthening our controls and procedures, in the future those controls and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our financial statements.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely basis.

Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects.

If we identify any new material weaknesses in the future, any such newly identified material weakness could limit our ability to prevent or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting and the price of our securities may decline as a result. We cannot assure you that any measures we may take in the future, will be sufficient to avoid potential future material weaknesses.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.


None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

 


 

Item 6. Exhibits.  

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit

Number

 

Description

    1.1

 

Underwriting Agreement, dated February 9, 2021, between the Company and Goldman Sachs & Co. LLC.(1)

    3.1

 

Amended and Restated Memorandum and Articles of Association.(1)

    4.1

 

Specimen Unit Certificate. (2)

    4.2

 

Specimen Class A Ordinary Share Certificate. (2)

    4.3

 

Specimen Warrant Certificate. (2)

    4.4

 

Warrant Agreement between Continental Stock Transfer & Trust Company and the Company. (1)

  10.1

 

Private Placement Warrants Purchase Agreement, dated February 9, 2021, between the Company and the Sponsor. (1)

  10.2

 

Investment Management Trust Agreement, dated February 9, 2021, between the Company and Continental Stock Transfer & Trust Company. (1)

  10.3

 

Registration and Shareholder Rights Agreement, dated February 9, 2021, among the Company, the Sponsor and certain other equity holders named therein. (1)

  10.4

 

Letter Agreement, dated February 9, 2021, among the Company, the Sponsor and the Company’s officers and directors. (1)

  10.5

 

Administrative Support Agreement, dated February 9, 2021, between the Company and Lazard Group LLC. (1)

  10.6

 

Securities Subscription Agreement, dated as of December 17, 2020, between the Company and the Sponsor. (2)

  10.7

 

SecondThird Amended and Restated Working Capital Promissory Note, dated as of August 5, 2021,March 30, 2022, between the Company and the Sponsor.(4)(3)

  10.8

 

Form of Indemnity Agreement(2)

  31.1*

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

  31.2*

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

  32.1**

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

  32.2**

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

 

Inline XBRL Instance Document

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

 

Cover Page Interactive Data File

 

*

Filed herewith.

**

Furnished.

(1)

Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 12, 2021.

(2)

Incorporated by reference to the Company’s Registration Statement on Form S-1 (SEC File No. 333-252408).

(3)

Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 31, 2021.

(4)

Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on August 6, 2021.2022.

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

LAZARD GROWTH ACQUISITION CORP. I

 

 

 

 

Date: December 17, 2021November 1, 2022

 

By:

/s/ Eyal Ofir

 

 

 

Eyal Ofir

 

 

 

Chief Executive Officer

 

 

 

 

Date: December 17, 2021November 1, 2022

 

By:

 /s/ Mary Ann Deignan

 

 

 

Mary Ann Deignan

 

 

 

Chief Financial Officer

 

3022